Loading organizations...
§ Private Equity · Suzhou, Jiangsu, China
Zhongxin Capital is an investment firm.
Zhongxin Capital is an investment firm established in November 2015 and headquartered in Suzhou, China. The firm operates as a venture capital and private equity entity, focusing on value-driven investments within China's life and health sector. It targets both venture and growth opportunities, aiming to support innovation and development in this specialized industry.
Operating under the name Baheal Zhongxin Capital on its official website, the firm positions itself as a leading investor dedicated to fostering advancements in the life and health domain. Its strategic approach includes acting as an executive agency for innovation incubation and investment within its core sector.
Zhongxin Capital was established in November 2015 and is headquartered in Suzhou, China.
Yes, Zhongxin Capital also acts as an executive agency for innovation incubation and investment within the life and health sector.
Zhongxin Capital was established in November 2015 and is headquartered in Suzhou, China.
Yes, Zhongxin Capital also acts as an executive agency for innovation incubation and investment within the life and health sector.
Zhongxin Capital, legally known as Suzhou Zhongxin Innovation Investment Management Co., Ltd., was founded in November 2015. Based in Suzhou, China, the firm functions as a private equity and venture capital entity. Its primary objective is to identify and capitalize on investment opportunities within the dynamic life and health sector across China.
The firm's investment strategy is centered on value creation, with a specific emphasis on venture and growth-stage companies. Zhongxin Capital seeks to support enterprises that are driving innovation and development within its specialized industry focus. This targeted approach allows the firm to concentrate its resources and expertise on a sector it identifies as critical for future growth.
Beyond direct investment, Zhongxin Capital also plays an operational role in the ecosystem. It acts as an executive agency for innovation incubation and investment, indicating a hands-on approach to nurturing new ventures and technologies. This dual function underscores its commitment to not only funding but also actively contributing to the development of the life and health sector.
Operating with a clear mandate, Zhongxin Capital positions itself as a significant investor in its chosen field. Its establishment in 2015 marked its entry into the investment landscape, and since then, it has maintained a focus on specialized opportunities within the Chinese market.
Zhongxin Capital has 1 tracked investment across 1 company. The latest tracked deal is $3.6M Seed in Nabowang in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 3, 2026 | Nabowang | $3.6M Seed | — | Guotai Junan Innovation Investment, Jinyu Maowu, Jiuhe Shenhong |